Details
Stereochemistry | ACHIRAL |
Molecular Formula | 3I.Sb |
Molecular Weight | 502.473 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Sb+3].[I-].[I-].[I-]
InChI
InChIKey=KWQLUUQBTAXYCB-UHFFFAOYSA-K
InChI=1S/3HI.Sb/h3*1H;/q;;;+3/p-3
Molecular Formula | Sb |
Molecular Weight | 121.76 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | HI |
Molecular Weight | 127.9124 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Substantiation of maximum permissible levels of antimony trioxide and pentasulide in the atmospheric air of inhabitated places]. | 1989 Apr |
|
Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets. | 2010 Jul 19 |
|
Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes. | 2012 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:01:35 GMT 2023
by
admin
on
Fri Dec 15 16:01:35 GMT 2023
|
Record UNII |
52ZE5Y9Y82
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C579
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C87427
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
232-205-8
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
ANTIMONY TRIIODIDE
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
437
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
52ZE5Y9Y82
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
DTXSID1064875
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
24630
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
7790-44-5
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
52ZE5Y9Y82
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | |||
|
1423913
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | RxNorm | ||
|
m1968
Created by
admin on Fri Dec 15 16:01:35 GMT 2023 , Edited by admin on Fri Dec 15 16:01:35 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |